At diagnosis, half of adults with ANCA-associated vasculitis (AAV) already have signs of interstitial lung disease (ILD), a condition…
Articles by Steve Bryson, PhD
Lung complications are common among adults with ANCA-associated vasculitis (AAV), affecting four in five individuals throughout their disease course,…
Adults with ANCA-associated vasculitis (AAV) who test positive for antibodies against the myeloperoxidase (MPO) protein may face cardiovascular events…
Tavneos (avacopan), in combination with standard treatment, induced disease remission within six months in nearly all adults with…
Physicians experienced in treating ANCA-associated vasculitis (AAV) generally agree on which disease manifestations are driven by granulomas, or…
CD11b, a protein found on the surface of neutrophils — immune cells that are first responders in fighting infections in…
Facial palsy, or weakness of the facial muscles, is associated with a nearly 10 times higher risk of hearing loss…
Researchers have identified new contributors to the abnormal immune responses against the myeloperoxidase (MPO)Â enzyme that drive ANCA-associated vasculitis (AAV)…
The frequency of ANCA-associated vasculitis (AAV) among the Indigenous peoples of Alaska is high compared with other populations worldwide,…
Among ANCA-associated vasculitis (AAV) patients with kidney failure and waiting for a kidney transplant, undergoing the transplant reduces their…